Empower Clinic Services LLC, a compounding pharmacy based in Houston, has petitioned the U.S. Patent Trial and Appeal Board (PTAB) to invalidate Eli Lilly & Co. Read More »

Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »

The Michigan Department of Licensing and Regulatory Affairs (LARA) has introduced its inaugural podcast, "LARA Living Room," during the Mackinac Policy Conference. Read More »

The National Consumers League (NCL) has announced the results of a national Morning Consult poll, which reveals significant public support for comprehensive reforms to the 340B Drug Pricing Program. Read More »

Pfizer and Moderna are required to update their COVID-19 vaccine labels to include stronger warnings about potential heart damage, according to the U.S. Food and Drug Administration (FDA). Read More »

Americans are expressing a strong desire for increased accountability from pharmaceutical companies regarding vaccine safety, according to a recent poll. Read More »

The Georgia Board of Pharmacy has issued a safety alert regarding compromised drug products. Read More »

The National Community Pharmacists Association (NCPA) has expressed approval following the House of Representatives' passage of a budget reconciliation bill. Read More »

As Memorial Day approaches, the Michigan Department of Licensing and Regulatory Affairs (LARA) and the Bureau of Fire Services (BFS) are urging residents to prioritize safety during their celebrations, particularly when it comes to grilling. Read More »

The Arkansas Department of Health (ADH) has recognized Mena Regional Health System as an Arkansas Stroke Ready Hospital (ArSRH). Read More »

PIERRE, S.D. – The Great Plains Zoo has reported that a bat found on its premises tested positive for rabies. Read More »

Gerard Acloque, a doctor at The Florida Concierge Medicine & Wellness, expressed concerns over Eli Lilly's legal actions against compounding pharmacies and telehealth companies producing compounded Tirzepatide. Read More »

Pharmacists United for Truth and Transparency said that pharmacy benefit managers (PBMs) are the primary driver of high drug prices in the United States, emphasizing how PBMs profit from negotiated savings. Read More »

May is Better Hearing and Speech Month, and the Arkansas Department of Health (ADH) aims to raise awareness about the importance of newborn hearing tests and language development milestones in children. Read More »

Monty's Home Medical has announced that compounded pharmaceuticals offer a customized solution to patient care by adjusting medications to individual needs, including dosage, form, and ingredients, for safer and more effective treatment. Read More »

Craig Brockie, founder of Ultimate Health Solutions, has expressed concerns about the priorities of large pharmaceutical companies. Read More »

The National Community Pharmacists Association (NCPA) has released a statement regarding President Trump's recent executive order on Most Favored Nation drug pricing. Read More »

Shaun Noorian, CEO of Empower Pharmacy, said that the U.S. pharmaceutical industry distorts global drug markets through excessive lobbying and anti-competitive practices. Read More »

The Arkansas Department of Health (ADH) is organizing a measles, mumps, and rubella (MMR) vaccine clinic at the Don Owen Sports Complex in Conway on May 13. Read More »

The National Library of Medicine has announced that compounded medications offer therapeutic alternatives for patients with unique medical needs that cannot be met by U.S. Food and Drug Administration (FDA)-approved drugs. Read More »